CREBBP/EP300 acetyltransferase inhibition targets lineage specific enhancers to inhibit the proliferation of ER+ breast cancer cells [scATAC-Seq]

ABSTRACT: MCF7 cells were treated with a CREBBP/EP300 acetyltransferase inhibitor CPI-1612 and chromatin status was measured via single-cell ATAC-seq

ORGANISM(S): Homo sapiens

PROVIDER: GSE190162 | GEO | 2022/03/04

REPOSITORIES: GEO